Amrize (NYSE:AMRZ) Stock Picked Up by Analysts at Longbow Research

Key Points

• Longbow Research initiated coverage of Amrize with a “buy” rating. However, the broader analyst consensus remains “Hold,” with 1 Strong Buy, 8 Buys, 7 Holds and 4 Sells, and an average price target of $50.24.
• Amrize shares opened at $36.20, near their 52-week low of $35.78 and well below the 52-week high of $65.94. The company recently reported quarterly EPS of $0.88, missing the $0.92 consensus estimate, on revenue of $3.49 billion.
• Company insiders bought nearly 49,000 shares worth about $2.16 million in the latest quarter, including purchases by an insider and the CFO. Insiders own approximately 0.54% of Amrize’s outstanding shares.

Longbow Research initiated coverage on shares of Amrize (NYSE:AMRZ - Get Free Report) in a research report issued on Monday, Briefing.com reports. The firm set a "buy" rating on the stock.

Several other equities research analysts have also weighed in on AMRZ. DA Davidson set a $40.00 target price on Amrize in a report on Friday. Wells Fargo & Company decreased their target price on Amrize from $44.00 to $40.00 and set an "equal weight" rating for the company in a research report on Monday, October 5th. Stephens lowered their price target on Amrize from $65.00 to $54.00 and set an "overweight" rating on the stock in a report on Wednesday, August 12th. Barclays initiated coverage on Amrize in a report on Thursday, October 1st. They set an "equal weight" rating and a $55.00 price target on the stock. Finally, JPMorgan Chase & Co. lowered shares of Amrize from an "overweight" rating to a "neutral" rating and dropped their price target for the company from $57.00 to $52.00 in a research report on Wednesday, September 2nd. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, seven have issued a Hold rating and four have assigned a Sell rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of "Hold" and an average price target of $50.24.

Amrize Price Performance

NYSE AMRZ opened at $36.20 on Monday. Amrize has a fifty-two week low of $35.78 and a fifty-two week high of $65.94. The stock's 50-day moving average is $42.33 and its two-hundred day moving average is $49.43. The firm has a market cap of $20.02 billion, a P/E ratio of 16.68, a price-to-earnings-growth ratio of 1.27 and a beta of 0.20. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.10 and a quick ratio of 0.73.

Amrize (NYSE:AMRZ - Get Free Report) last released its quarterly earnings results on Thursday, August 6th. The company reported $0.88 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.92 by ($0.04). The company had revenue of $3.49 billion for the quarter. Amrize had a return on equity of 10.22% and a net margin of 9.89%. On average, analysts anticipate that Amrize will post 2.46 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Amrize news, insider Jaime Hill acquired 1,500 shares of the company's stock in a transaction dated Tuesday, August 11th. The shares were acquired at an average cost of $47.12 per share, for a total transaction of $70,680.00. Following the completion of the purchase, the insider owned 29,698 shares of the company's stock, valued at approximately $1,399,369.76. This trade represents a 5.32% increase in their position. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CFO Baris Oran acquired 3,000 shares of the company's stock in a transaction dated Tuesday, August 11th. The stock was acquired at an average price of $47.38 per share, for a total transaction of $142,140.00. Following the completion of the purchase, the chief financial officer directly owned 3,000 shares of the company's stock, valued at $142,140. This trade represents a ∞ increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders acquired a total of 48,983 shares of company stock valued at $2,158,755 in the last quarter. Insiders own 0.54% of the company's stock.

Institutional Trading of Amrize

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in AMRZ. Caldwell Sutter Capital Inc. raised its position in shares of Amrize by 11.5% during the first quarter. Caldwell Sutter Capital Inc. now owns 2,675 shares of the company's stock valued at $150,000 after buying an additional 275 shares during the last quarter. Grove Bank & Trust lifted its stake in shares of Amrize by 2.1% in the third quarter. Grove Bank & Trust now owns 17,477 shares of the company's stock valued at $653,000 after buying an additional 353 shares during the period. Baldwin Investment Management LLC lifted its stake in shares of Amrize by 4.4% in the fourth quarter. Baldwin Investment Management LLC now owns 8,980 shares of the company's stock valued at $486,000 after buying an additional 375 shares during the period. Mengis Capital Management Inc. lifted its stake in shares of Amrize by 8.5% in the fourth quarter. Mengis Capital Management Inc. now owns 5,750 shares of the company's stock valued at $311,000 after buying an additional 450 shares during the period. Finally, Norman Fields Gottscho Capital Management LLC grew its position in Amrize by 4.3% during the second quarter. Norman Fields Gottscho Capital Management LLC now owns 11,515 shares of the company's stock worth $614,000 after buying an additional 475 shares in the last quarter.

About Amrize

Amrize Ltd. is a North American building solutions company that produces and supplies essential construction materials and related products. Its portfolio includes cement, aggregates, ready-mix concrete, asphalt, concrete products and roofing systems used in residential, commercial and infrastructure projects.

The company serves customers across the United States and Canada through a network of production facilities, distribution locations and other operating sites. Its products support a range of construction applications, including roads, bridges, buildings, homes and other major infrastructure.

Amrize was established as the result of the separation of Holcim's North American business and began operating as an independent, publicly traded company in 2025.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.